{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:43:43Z","timestamp":1755999823438,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Emergency percutaneous coronary intervention (PCI) is a common treatment for ST-elevated myocardial infarction (STEMI) patients. However, the coronary slow flow\/no\u00a0reflow phenomenon (CSF\/NRP) can occur as a complication during or after the procedure. Identifying predictors of CSF\/NRP after emergency PCI in STEMI patients can help clinicians anticipate and prevent this complication. In this study, we aimed to investigate clinical, laboratory, and procedural factors that may contribute to the development of CSF\/NRP in STEMI patients undergoing PCI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 460 patients were included in this study, with a mean\u00a0(\u00b1 SD) age of 60\u2009\u00b1\u200912.5 years. The incidence of CSF\/NRP was 30.2% (n\u2009=\u2009139) among the study population. The univariate analysis showed that older age, lower left ventricular ejection fraction (LVEF), initial thrombolysis in myocardial infarction (TIMI)flow grade 0\u20132, increased creatinine level, lower estimated glomerular filtration rate (eGFR), diffuse target lesion length, and longer length of stent were significantly associated with the occurrence of CSF\/NRP (p\u2009&lt;\u20090.05). However, in the multivariate logistic regression model, only eGFR (OR\u2009=\u20090.98, 95% CI: 0.96\u20130.99, p\u2009=\u20090.005), diffuse target lesion length (OR\u2009=\u20092.15, 95% CI: 1.20\u20133.83, p\u2009=\u20090.009) and LVEF (OR\u2009=\u20090.96, 95% CI: 0.94\u20130.98, p\u2009=\u20090.004) remained significant predictors of CSF\/NRP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study demonstrated that diffuse lesion length, lower LVEF, and lower eGFR can be considered as independent predictors of CSF\/NRP in STEMI patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-024-00577-0","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T12:02:43Z","timestamp":1730721763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical, laboratory, and procedural predictors of slow\u00a0flow\/no\u00a0reflow phenomenon after emergency percutaneous coronary interventions in ST-elevated myocardial infarction"],"prefix":"10.1186","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8716-8137","authenticated-orcid":false,"given":"Fatemeh","family":"Bamarinejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-3572","authenticated-orcid":false,"given":"Mohammad","family":"Kermani-alghoraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2529-5223","authenticated-orcid":false,"given":"Azam","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-0431","authenticated-orcid":false,"given":"Hamidreza","family":"Roohafza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safoura","family":"Yazdekhasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maedeh","family":"Azarm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-7748","authenticated-orcid":false,"given":"Atefeh","family":"Bamarinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7179-5558","authenticated-orcid":false,"given":"Masoumeh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"issue":"1","key":"577_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/JICC.JICC_72_20","volume":"12","author":"SN Kanthallu","year":"2022","unstructured":"Kanthallu SN, Sathyamurthy I (2022) Coronary slow flow\/no-reflow: revisited. J Indian Coll Cardiol 12(1):8\u201313","journal-title":"J Indian Coll Cardiol"},{"issue":"1","key":"577_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0002-8703(72)90307-9","volume":"84","author":"AA Tambe","year":"1972","unstructured":"Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E (1972) Angina pectoris and slow flow velocity of dye in coronary arteries\u2014a new angiographic finding. Am Heart J 84(1):66\u201371","journal-title":"Am Heart J"},{"issue":"2","key":"577_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","volume":"125","author":"G Niccoli","year":"2019","unstructured":"Niccoli G, Montone RA, Ibanez B, Thiele H, Crea F, Heusch G et al (2019) Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve prognosis. Circ Res 125(2):245\u2013258","journal-title":"Circ Res"},{"issue":"13","key":"577_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","volume":"37","author":"G Niccoli","year":"2016","unstructured":"Niccoli G, Scalone G, Lerman A, Crea F (2016) Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J 37(13):1024\u20131033","journal-title":"Eur Heart J"},{"issue":"4","key":"577_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1253\/circj.CJ-11-0959","volume":"76","author":"BM Hawkins","year":"2012","unstructured":"Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E (2012) Coronary slow flow-prevalence and clinical correlations. Circ J 76(4):936\u2013942","journal-title":"Circ J"},{"key":"577_CR6","first-page":"232470961878919","volume":"6","author":"C Alvarez","year":"2018","unstructured":"Alvarez C, Siu H (2018) Coronary slow-flow phenomenon as an underrecognized and treatable source of chest pain: case series and literature review. J Investig Med 6:2324709618789194","journal-title":"J Investig Med"},{"issue":"1","key":"577_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.34172\/jcvtr.2021.03","volume":"13","author":"M Rouzbahani","year":"2021","unstructured":"Rouzbahani M, Farajolahi S, Montazeri N, Janjani P, Salehi N, Rai A et al (2021) Prevalence and predictors of slow coronary flow phenomenon in Kermanshah province. J Cardiovasc Thorac Res 13(1):37","journal-title":"J Cardiovasc Thorac Res"},{"key":"577_CR8","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1016\/j.ihj.2018.06.001","volume":"70","author":"S Sanghvi","year":"2018","unstructured":"Sanghvi S, Mathur R, Baroopal A, Kumar A (2018) Clinical, demographic, risk factor and angiographic profile of coronary slow flow phenomenon: a single centre experience. Indian Heart J 70:S290-294","journal-title":"Indian Heart J"},{"issue":"4","key":"577_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","volume":"54","author":"G Niccoli","year":"2009","unstructured":"Niccoli G, Burzotta F, Galiuto L, Crea F (2009) Myocardial no-reflow in humans. J Am Coll Cardiol 54(4):281\u2013292","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"577_CR10","first-page":"108","volume":"13","author":"M Alidoosti","year":"2018","unstructured":"Alidoosti M, Lotfi R, Lotfi-Tokaldany M, Nematipour E, Salarifar M, Poorhosseini H et al (2018) Correlates of the \u201cno-reflow\u201d or \u201cslow-flow\u201d phenomenon in patients undergoing primary percutaneous coronary intervention. J Tehran Univ Hear Cent 13(3):108","journal-title":"J Tehran Univ Hear Cent"},{"issue":"2","key":"577_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0735-1097(01)01405-X","volume":"38","author":"K Iwakura","year":"2001","unstructured":"Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A et al (2001) Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 38(2):472\u2013477","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"577_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/MCA.0b013e32835c4719","volume":"24","author":"DY Sahin","year":"2013","unstructured":"Sahin DY, G\u00fcr M, Elbasan Z, Kuloglu O, Seker T, Kivrak A et al (2013) SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron Artery Dis 24(2):148\u2013153","journal-title":"Coron Artery Dis"},{"issue":"1","key":"577_CR13","doi-asserted-by":"publisher","first-page":"102074","DOI":"10.1016\/j.cpcardiol.2023.102074","volume":"49","author":"J Yu","year":"2023","unstructured":"Yu J, Yi D, Yang C, Zhou X, Wang X, Zhang Z et al (2023) Major adverse cardiovascular events and prognosis in patients with coronary slow flow. Curr Probl Cardiol 49(1):102074","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"577_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/MCA.0000000000001362","volume":"35","author":"A Bamarinejad","year":"2024","unstructured":"Bamarinejad A, Kermani-Alghoraishi M, Soleimani A, Roohafza H, Yazdekhasti S, MirmohammadSadeghi A, et al (2024) Long-term outcome and prognostic value of angiographic slow\/no-reflow phenomenon after emergency percutaneous coronary intervention for ST-elevation myocardial infarction. Coron Artery Dis 35(5):389\u2013396.\u00a0","journal-title":"Coron Artery Dis"},{"issue":"1","key":"577_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-017-0722-z","volume":"18","author":"X Niu","year":"2018","unstructured":"Niu X, Zhang J, Bai M, Peng Y, Sun S, Zhang Z (2018) Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis. BMC Cardiovasc Disord 18(1):1\u201315","journal-title":"BMC Cardiovasc Disord"},{"key":"577_CR16","doi-asserted-by":"publisher","first-page":"S406","DOI":"10.1016\/j.ihj.2018.01.032","volume":"70","author":"JK Fajar","year":"2018","unstructured":"Fajar JK, Heriansyah T, Rohman MS (2018) The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: a meta-analysis. Indian Heart J 70:S406-418","journal-title":"Indian Heart J"},{"issue":"3","key":"577_CR17","first-page":"1","volume":"17","author":"M Sadeghi","year":"2021","unstructured":"Sadeghi M, Soleimani A, Sarrafzadegan N, Askari M, Nouri F, Masoumi G et al (2021) Background and design of a 5-year ST Elevation Myocardial Infarction Cohort in Isfahan, Iran: SEMI-CI study. ARYA Atheroscler 17(3):1","journal-title":"ARYA Atheroscler"},{"issue":"14","key":"577_CR18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJM198504043121437","volume":"312","author":"Group* TS","year":"1985","unstructured":"Group* TS (1985) The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 312(14):932\u2013936","journal-title":"N Engl J Med"},{"issue":"1","key":"577_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault H (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31\u201341","journal-title":"Nephron"},{"key":"577_CR20","unstructured":"Bois D (1989) A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5:303."},{"issue":"10","key":"577_CR21","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1253\/circj.CJ-21-0221","volume":"85","author":"T Kai","year":"2021","unstructured":"Kai T, Oka S, Hoshino K, Watanabe K, Nakamura J, Abe M et al (2021) Renal dysfunction as a predictor of slow-flow\/no-reflow phenomenon and impaired ST segment resolution after percutaneous coronary intervention in ST-elevation myocardial infarction with initial thrombolysis in myocardial infarction grade 0. Circ J 85(10):1770\u20131778","journal-title":"Circ J"},{"issue":"4","key":"577_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/MCA.0000000000000726","volume":"30","author":"O Tasar","year":"2019","unstructured":"Tasar O, Karabay AK, Oduncu V, Kirma C (2019) Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis 30(4):270\u2013276","journal-title":"Coron Artery Dis"},{"key":"577_CR23","first-page":"1","volume":"2021","author":"G Gao","year":"2021","unstructured":"Gao G, Xu H, Zhang D, Song C, Guan C, Xu B et al (2021) The predictive value of baseline target lesion SYNTAX score for no-reflow during urgent percutaneous coronary intervention in acute myocardial infarction. J Interv Cardiol 2021:1\u20139","journal-title":"J Interv Cardiol"},{"issue":"4","key":"577_CR24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","volume":"36","author":"I Morishima","year":"2000","unstructured":"Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H et al (2000) Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36(4):1202\u20131209","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"577_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0735-1097(94)90305-0","volume":"24","author":"DS Celermajer","year":"1994","unstructured":"Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE (1994) Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24(2):471\u2013476","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"577_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ihj.2016.04.006","volume":"68","author":"S Gupta","year":"2016","unstructured":"Gupta S, Gupta MM (2016) No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Indian Heart J 68(4):539\u2013551","journal-title":"Indian Heart J"},{"key":"577_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00380-017-1050-z","volume":"33","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Sakakura K, Taniguchi Y, Yamamoto K, Wada H, Fujita H et al (2018) Determinants of slow flow following stent implantation in intravascular ultrasound-guided primary percutaneous coronary intervention. Heart Vessels 33:226\u2013238","journal-title":"Heart Vessels"},{"issue":"12","key":"577_CR28","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1002\/clc.20634","volume":"33","author":"L Dong-bao","year":"2010","unstructured":"Dong-bao L, Qi H, Zhi L, Shan W, Wei-ying J (2010) Predictors and long-term prognosis of angiographic slow\/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction. Clin Cardiol 33(12):E7-12","journal-title":"Clin Cardiol"},{"issue":"5","key":"577_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1253\/circj.72.716","volume":"72","author":"C Kirma","year":"2008","unstructured":"Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM et al (2008) Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions Experience at a Single Center. Circ J 72(5):716\u2013721","journal-title":"Circ J"},{"issue":"3","key":"577_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcin.2016.11.059","volume":"10","author":"SH Rezkalla","year":"2017","unstructured":"Rezkalla SH, Stankowski RV, Hanna J, Kloner RA (2017) Management of no-reflow phenomenon in the catheterization laboratory. JACC Cardiovasc Interv 10(3):215\u2013223","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"577_CR31","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1378\/chest.122.4.1322","volume":"122","author":"H-K Yip","year":"2002","unstructured":"Yip H-K, Chen M-C, Chang H-W, Hang C-L, Hsieh Y-K, Fang C-Y et al (2002) Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 122(4):1322\u20131332","journal-title":"Chest"},{"issue":"2","key":"577_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.amjcard.2012.09.015","volume":"111","author":"RW Harrison","year":"2013","unstructured":"Harrison RW, Aggarwal A, Ou F, Klein LW, Rumsfeld JS, Roe MT et al (2013) Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol 111(2):178\u2013184","journal-title":"Am J Cardiol"},{"key":"577_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjcard.2022.01.044","volume":"171","author":"R Kumar","year":"2022","unstructured":"Kumar R, Ammar A, Saghir T, Sial JA, Khan KA, Shah JA et al (2022) Development and Validation of a Novel Risk Stratification Model for Slow-Flow\/No-Reflow During Primary Percutaneous Coronary Intervention (the RK-SF\/NR Score). Am J Cardiol 171:32\u201339","journal-title":"Am J Cardiol"},{"issue":"13","key":"577_CR34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJM200009283431303","volume":"343","author":"JA Goldstein","year":"2000","unstructured":"Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O\u2019Neill WW (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343(13):915\u2013922","journal-title":"N Engl J Med"},{"issue":"12","key":"577_CR35","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1136\/hrt.2007.135822","volume":"94","author":"J-H Bae","year":"2008","unstructured":"Bae J-H, Kwon T-G, Hyun D-W, Rihal CS, Lerman A (2008) Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study. Heart 94(12):1559\u20131564","journal-title":"Heart"},{"issue":"1","key":"577_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijcard.2008.03.058","volume":"136","author":"T Celik","year":"2009","unstructured":"Celik T, Iyisoy A, Yuksel UC, Jata B, Ozkan M (2009) The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: the role of inflammation. Int J Cardiol 136(1):86\u201388","journal-title":"Int J Cardiol"},{"issue":"4","key":"577_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jcmg.2008.04.004","volume":"1","author":"YJ Hong","year":"2008","unstructured":"Hong YJ, Jeong MH, Ahn Y, Sim DS, Chung JW, Cho JS et al (2008) Plaque prolapse after stent implantation in patients with acute myocardial infarction: an intravascular ultrasound analysis. JACC Cardiovasc Imaging 1(4):489\u2013497","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"577_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jjcc.2009.03.003","volume":"54","author":"YJ Hong","year":"2009","unstructured":"Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, Kang WY et al (2009) Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction. J Cardiol 54(1):36\u201344","journal-title":"J Cardiol"},{"key":"577_CR39","doi-asserted-by":"crossref","unstructured":"Groenland FTW, Ziedses des Plantes AC, Neleman T, Scoccia A, Ligthart JMR, Witberg KT, et al (2023) Culprit lesion plaque characterization and thrombus grading by high\u2010definition intravascular ultrasound in patients with ST\u2010segment elevation myocardial infarction. Catheter Cardiovasc Interv","DOI":"10.1002\/ccd.30699"},{"issue":"1","key":"577_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15171\/jcvtr.2018.08","volume":"10","author":"F Mirbolouk","year":"2018","unstructured":"Mirbolouk F, Gholipour M, Salari A, Shakiba M, Kheyrkhah J, Nikseresht V et al (2018) CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. J Cardiovasc Thorac Res 10(1):46","journal-title":"J Cardiovasc Thorac Res"},{"key":"577_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2023.05.011","volume":"384","author":"\u00d6 Gen\u00e7","year":"2023","unstructured":"Gen\u00e7 \u00d6, Y\u0131ld\u0131r\u0131m A, Al\u0131c\u0131 G, Harbal\u0131o\u011flu H, Quisi A, Erdo\u011fan A et al (2023) Thromboembolic risk scores in patients with non-obstructive coronary architecture with and without coronary slow flow: a case-control study. Int J Cardiol 384:1\u20139","journal-title":"Int J Cardiol"},{"key":"577_CR42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10157-019-01718-5","volume":"23","author":"H Fujii","year":"2019","unstructured":"Fujii H, Kono K, Nishi S (2019) Characteristics of coronary artery disease in chronic kidney disease. Clin Exp Nephrol 23:725\u2013732","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"577_CR43","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/echo.15445","volume":"39","author":"V Jain","year":"2022","unstructured":"Jain V, Gupta K, Bhatia K, Rajapreyar I, Singh A, Zhou W et al (2022) Coronary flow abnormalities in chronic kidney disease: a systematic review and meta-analysis. Echocardiography 39(11):1382\u20131390","journal-title":"Echocardiography"},{"issue":"7","key":"577_CR44","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/0003319714546738","volume":"66","author":"A Kurtul","year":"2015","unstructured":"Kurtul A, Murat SN, Yarlioglues M, Duran M, Celik IE, Kilic A (2015) Mild to moderate renal impairment is associated with no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. Angiology 66(7):644\u2013651","journal-title":"Angiology"},{"key":"577_CR45","doi-asserted-by":"publisher","first-page":"856","DOI":"10.36660\/abc.20190905","volume":"116","author":"MA Huyut","year":"2021","unstructured":"Huyut MA (2021) Comparison of the outcomes between coronary no-reflow and slow-flow phenomenon in non-STEMI patients. Arq Bras Cardiol 116:856\u2013864","journal-title":"Arq Bras Cardiol"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-024-00577-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-024-00577-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-024-00577-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T23:02:37Z","timestamp":1730761357000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-024-00577-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1186\/s43044-024-00577-0","relation":{},"ISSN":["2090-911X"],"issn-type":[{"type":"electronic","value":"2090-911X"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"18 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research obtained ethical clearance from the Ethics Committee of Isfahan University of Medical Sciences, adhering to the ethical guidelines outlined in the Declaration of Helsinki, with the ethics code: IR.MUI.MED.REC.1400.601. The researchers obtained written informed consent from all participants involved in the study. If they had loss of consciousness, the first relatives signed the form. All participants were over 16 years of age.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}